Insulet Announces CE Mark Approval of Omnipod 5 Integration with Abbott FreeStyle Libre 2 Plus Sensor

07.02.2024 - Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced it has received CE mark approval under the European Medical Device Regulation for ... Seite 1

Related Keywords

Netherlands ,United Kingdom ,Patrick Crannell ,Smartadjust Technology ,Insulin Delivery System ,Abbott Freestyle Libre ,Business Wire ,Senior Vice President ,International General Manager ,Freestyle Libre ,Insulet Chart ,Nsulet Kurs ,Nsulet Aktie ,